Skip to main content
Veterinary Medicines

Luminal vet, 100 mg tablets for dogs

Authorised
  • Phenobarbital

Product identification

Medicine name:
Epirepress 100 mg, comprimidos para cães
Luminal vet, 100 mg tablets for dogs
Active substance:
  • Phenobarbital
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenobarbital
    100.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN03AA02
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • (ID7) 120 Tablet: unspecified outer container with 1 Container (High Density PolyEthylene) with 120 Tablet
  • (ID6) 100 Tablet: unspecified outer container with 1 Container (High Density PolyEthylene) with 100 Tablet
  • (ID5) 60 Tablet: unspecified outer container with 1 Container (High Density PolyEthylene) with 60 Tablet
  • (ID4) 50 Tablet: unspecified outer container with 1 Container (High Density PolyEthylene) with 50 Tablet
  • (ID3) 180 Tablet: unspecified outer container with 6 Bottle (Glass) each with 30 Tablet
  • (ID2) 90 Tablet: unspecified outer container with 3 Bottle (Glass) each with 30 Tablet
  • (ID1) 30 Tablet: unspecified outer container with 1 Bottle (Glass) with 30 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Desitin Arzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Desitin Arzneimittel GmbH
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 711/02/13RFVPT
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0141/002
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Netherlands
  • Portugal
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."